Serafini, Caroline E.
Gorti, Viswanath
Casteleiro Costa, Paloma
Silva Trenkle, Aaron D.
Kanwar, Bharat
Wang, Bryan
Wicker, Brian
Kippner, Linda E.
LeCompte, Isaac
Chen, Rui Qi
Joffe, Benjamin
Li, Ye
Bowles-Welch, Annie C.
Li, Jing
Brown, Christine E.
Kwong, Gabriel A.
Balakirsky, Stephen
Roy, Krishnendu
Robles, Francisco E.
Funding for this research was provided by:
National Science Foundation Graduate Research Fellowship Program (NSF GRFP DGE-2039655)
National Science Foundation Graduate Research Fellowship Program (NSF GRFP DGE-2039655)
National Institutes of Health Cell and Tissue Engineering Training Program (T32GM145735)
National Institutes of Health Cell and Tissue Engineering Training Program (T32GM145735)
National Institute of Allergy and Infectious Diseases (R01AI171892)
Burroughs Wellcome Fund (CASI BWF 1014540)
National Institute of General Medical Sciences (R35GM147437)
The Billie and Bernie Marcus Foundation
Georgia Tech Research Institute Independent Research and Development (IRAD) funds
Georgia Institute of Technology
Article History
Received: 16 June 2025
Accepted: 15 October 2025
First Online: 27 November 2025
Competing interests
: G.A.K. reports equity or consulting roles for Sunbird Bio, Port Therapeutics, Send Biotherapeutics, and Ridge Biotechnologies. All other authors declare they have no competing interests.